ArticleProceedings of the National Academy of Sciences of the United States of America2004

Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs.

M Golam Mohi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.